Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Muir

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
Life Science Alliance|December 29, 2019
Oscillatory cAMP signaling rapidly alters H3K4 methylationTyler C Huff, Vladimir Camarena, David W Sant, et al.
British Journal of Cancer|May 29, 2008
Diagnostic radiation procedures and risk of prostate cancerP Myles, S Evans, A Lophatananon, et al.
The Journal of Experimental Medicine|March 9, 2022
Ferrous iron-activatable drug conjugate achieves potent MAPK blockade in KRAS-driven tumorsHonglin Jiang, Ryan K Muir, Ryan L Gonciarz, et al.
British Journal of Cancer|December 10, 2009
Mutation analysis of the MSMB gene in familial prostate cancerZ Kote-Jarai, D Leongamornlert, M Tymrakiewicz, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Mixed Alkyl/Aryl Phosphonates Identify Metabolic Serine Hydrolases as Antimalarial TargetsJohn M Bennett, Sunil K Narwal, Stephanie Kabeche, et al.
ACS Infectious Diseases|September 15, 2023
Covalent Macrocyclic Proteasome Inhibitors Mitigate Resistance in <i>Plasmodium falciparum</i>John M Bennett, Kurt E Ward, Ryan K Muir, et al.
ACS Infectious Diseases|February 11, 2021
Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19Kas Steuten, Heeyoung Kim, John C Widen, et al.
British Journal of Cancer|January 8, 2009
A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancerZ Kote-Jarai, S Jugurnauth, S Mulholland, et al.
British Journal of Cancer|September 2, 2005
Mobile phone use and risk of acoustic neuroma: results of the Interphone case-control study in five North European countriesM J Schoemaker, A J Swerdlow, A Ahlbom, et al.
Andrology|July 17, 2019
Runs of homozygosity and testicular cancer riskC Loveday, A Sud, K Litchfield, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Life Science Alliance|December 29, 2019
Oscillatory cAMP signaling rapidly alters H3K4 methylationTyler C Huff, Vladimir Camarena, David W Sant, et al.
British Journal of Cancer|May 29, 2008
Diagnostic radiation procedures and risk of prostate cancerP Myles, S Evans, A Lophatananon, et al.
The Journal of Experimental Medicine|March 9, 2022
Ferrous iron-activatable drug conjugate achieves potent MAPK blockade in KRAS-driven tumorsHonglin Jiang, Ryan K Muir, Ryan L Gonciarz, et al.
British Journal of Cancer|December 10, 2009
Mutation analysis of the MSMB gene in familial prostate cancerZ Kote-Jarai, D Leongamornlert, M Tymrakiewicz, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Mixed Alkyl/Aryl Phosphonates Identify Metabolic Serine Hydrolases as Antimalarial TargetsJohn M Bennett, Sunil K Narwal, Stephanie Kabeche, et al.
ACS Infectious Diseases|September 15, 2023
Covalent Macrocyclic Proteasome Inhibitors Mitigate Resistance in <i>Plasmodium falciparum</i>John M Bennett, Kurt E Ward, Ryan K Muir, et al.
ACS Infectious Diseases|February 11, 2021
Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19Kas Steuten, Heeyoung Kim, John C Widen, et al.
British Journal of Cancer|January 8, 2009
A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancerZ Kote-Jarai, S Jugurnauth, S Mulholland, et al.
British Journal of Cancer|September 2, 2005
Mobile phone use and risk of acoustic neuroma: results of the Interphone case-control study in five North European countriesM J Schoemaker, A J Swerdlow, A Ahlbom, et al.
Andrology|July 17, 2019
Runs of homozygosity and testicular cancer riskC Loveday, A Sud, K Litchfield, et al.
Pageof 11